Aprea Therapeutics Inc.
APRE | NASDAQ
$0.74
-$0.02 (-2.62%)
At close: Sep 21, 2026, 4:00 PM ET
$0.80
+$0.06 (+8.11%)
After-hours:
Sep 21, 2026, 7:50 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -0.44 | -1.40 | -1.19 | 0 | -1.65 | -1.94 |
PEG Ratio | 0.02 | 0.03 | 0.01 | 0 | 0.05 | -0.02 |
PS Ratio | n/a | 12.06 | 29.15 | n/a | n/a | n/a |
PB Ratio | 0.45 | 0.94 | 0.93 | 0.02 | 1.23 | 1.34 |
P/FCF Ratio | -0.43 | -1.34 | -1.39 | -0.02 | -1.62 | -2.49 |
P/OCF Ratio | -0.43 | -1.34 | -1.40 | -0.02 | -1.62 | -2.49 |
OCF/S Ratio | n/a | -902.23 | -2.09K | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | 0 | 0 |
Quick Ratio | 5.63 | 7.01 | 5.14 | 9.42 | 7.73 | 6.03 |
Current Ratio | 5.63 | 7.01 | 5.14 | 9.42 | 7.73 | 6.03 |
Asset Turnover | n/a | 0.06 | 0.03 | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | -252.73 | n/a | -237.19 |
Return on Equity | -101.27% | -67.12% | -78.22% | -439.34% | -73.80% | -69.66% |
Return on Assets | -79.08% | -54.04% | -63.08% | -373.60% | -64.30% | -58.10% |
Return on Invested Capital | -100.49% | -69.45% | -84.71% | -420.68% | -75.35% | -67.94% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | -523.16% | 98.79% | n/a | n/a | n/a |
Net Profit Margin | n/a | -862.43% | -2.45K% | n/a | n/a | n/a |
Pretax Profit Margin | n/a | -862.43% | -2.45K% | n/a | n/a | n/a |
Operating Profit Margin | n/a | -953% | -2.65K% | n/a | n/a | n/a |
FCF Margin | n/a | -903.26% | -2.1K% | n/a | n/a | n/a |
EBITDA Margin | n/a | -860.94% | -2.45K% | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove APRE